In an investor presentation at the Wells Fargo 2023 Healthcare Conference, Neogen Corporation (NASDAQ: NEOG) disclosed preliminary Q1 FY24 core revenue growth slightly below expectations.
William Blair's estimate implies revenue about 5% below its and Street expectations (management provided growth ranges, so this is our initial assessment of the potential revenue figure).
- Animal safety Core revenue is expected to decline by high single-digit and Shift away from smaller production animals, contributing to softer Genomics sales.
- Legacy Food safety: Core revenue is ...